Brief: Sciclone Pharmaceuticals Posts HY Net Profit RMB532.2 Mln

SciClone Pharmaceuticals (Holdings)

19/08/2022 24:34

Aug 19 (Reuters) - SciClone Pharmaceuticals (Holdings) Ltd
 6600.HK :
    * HY NET PROFIT ABOUT RMB532.2 MILLION, ABOUT RMB90.5
MILLION
LOWER
    * HY CORE NET PROFIT FROM NORMAL BUSINESS OPERATION ABOUT
RMB653.0
MILLION, UP ABOUT 4.9%
    * HY REVENUE OF RMB1,475.1 MILLION WAS UP 10.8% OVER SAME
PERIOD
LAST YEAR

Further company coverage:  6600.HK 

 ((Reuters.Briefs@thomsonreuters.com;))